Prophylaxis for transrectal prostatic biopsies: A randomized controlled study of intravenous co-amoxiclav given as a single dose compared with an intravenous dose followed by oral co-amoxiclav for 24 h

British Journal of Urology

Volumn 81, Issue 4, 1998, Pages 529-531

  Bates, T S ^a   Porter, T ^a   Gingell, J C ^a  

^a SOUTHMEAD HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; CLAVULANIC ACID;

ANTIBIOTIC PROPHYLAXIS; ARTICLE; CLINICAL TRIAL; HUMAN; INFECTIOUS COMPLICATION; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; PROSTATE BIOPSY; RANDOMIZED CONTROLLED TRIAL; URINARY TRACT INFECTION;

ADMINISTRATION, ORAL; AGED; AMOXICILLIN-POTASSIUM CLAVULANATE COMBINATION; BACTERIAL INFECTIONS; BIOPSY, NEEDLE; DRUG THERAPY, COMBINATION; HUMANS; INFUSIONS, INTRAVENOUS; MALE; PROSPECTIVE STUDIES; PROSTATIC DISEASES; TREATMENT FAILURE;

EID: 0031844850     PISSN: 00071331     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1464-410x.1998.00588.x     Document Type: Article

References (14)

1. Catalona WJ, Smith DS, Ratliff TL, Basler JW. Detection of organ-confined prostate cancer is increased through prostate specific antigen based screening. JAMA 1993: 270: 948-54
2. Brewster SF. Antimicrobial prophylaxis for transrectal prostatic biopsy. Curr Opin Urol 1997: 7: 57-60
3. Aus G. Ahlgren G, Bergdahl S. Hugosson J. Infection after transrectal core biopsies of the prostate -risk factors and antibiotic prophylaxis. Br J Urol 1996: 77: 851-5
4. Wilson APR. Shrimpton S, Jaderberg M. A meta-analysis of the use of amoxycillin clavulanic acid in surgical prophylaxis. J Hosp Infect 1992: 22: 9-21
5. Brewster SF. Results of a questionnaire survey of antimicrobial prophylaxis for transrectal biopsy. Br J Urol 1992: 70: 696
6. furincic C, Klippel KF. Sietzen W. Lang A. Concentration of Amoxycillin and clavulanate in prostate tissue and in serum: a pharmacokinetic study. Proc. 15th ICC. Istanbul 1987: 209-10
7. Ball AP, Geddes AM. Davey PG. Farrell M. Brookes GR. Clavulanic acid and amoxycillin: a clinical, bacteriological and pharmacological study. Lancet 1980; 1: 620-3
8. Leng B. Augmentin in the treatment of urinary tract infections due to amoxycillin resistant bacteria. Proceeding of the European Symposium on Augmentin, Scheveningen. June 1982: 153-60
9. Hannan M. Cormican M. Flynn J. A comparison of antimicrobial sensitivities of urinary pathogens for the years 1980 and 1990. Irish J Med Sei 1993: 162:499-501
10. Gerding DN. Antibiotics in laboratory medicine. In Lorian V ed.. Extravascular Antimicrobial Distribution in Man, 2nd edn. Baltimore: Williams and Wilkins 1986: 978-81
11. Cooper DL. Gould JC. Horton R. Jackson D. Meikle G. Stefanski Sf. Tissue distribution of amoxycillin and clavulanate after intravenous administration of 0.6 and 1.2 g Augmentin. Proceedings of the 7th Mediterranean Congress of Chemotherapy, Barcelona, 1990 (abstract): 159
12. Scaglione F. Ferrara F. Cogo R et al. Pharmacokinetics and tissue penetration of clavulanic acid and amoxycillin given in combination and in a single intake. Proceedings of the 6th Mediterranean Congress of Chemotherapy. 1988 (abstract): 17
13. Slocombe B, Beale AS, Boon RJ et al. Antibacterial activity in vitro and in vivo of amoxycillin in the presence of clavulanic acid. Postgrad Med Argmentin Symposium Supplement 1984: 29-46
14. Ristuccia AM. Cunha BA. Current concepts in antimicrobial therapy of prostatitis. Urology 1982: 20: 338-45